Abstract:Abstract Mammography screening is widely used for earlier detection of breast cancer and has been shown to contribute to reduction of mortality and morbidity. Most screen-detected breast cancers are early stage, hormonal receptor-positive, HER2-negative (HR+ HER2-) breast cancers. The majority of HR+ HER2- cancers are assigned to molecular intrinsic subtypes of Luminal A and Luminal B, which generally harbour low recurrence risk, with Luminal B cases being more invasive but still less aggressive than HER2-enriched or Basal-like subtypes. However, some of these Luminal cancers later recur (5+ years after diagnosis) often as advanced and/or metastatic disease. We studied a cohort of screen-detected breast cancers (42 cases) at Sunnybrook Health Sciences Centre (Toronto, ON Canada) with integrated cross-platform radiomics, molecular and proteomic analysis in an attempt to better characterise these cancers and their proclivity for late recurrence. Utilising a Nanostring 200-gene assay, the molecular subtypes (PAM50 and MammaTyper-like) and a range of recapitulated clinical prognostic scores (50-Gene, 70-Gene and 21-Gene Risk) were determined for these cancers. While a majority of cases (29 out of 42) were subtyped as Luminal A cancers by PAM50, a fraction (12 out of 29) of these were either subtyped as Luminal B/HER2+ based on MammaTyper-like results, or measured as intermediate to high risk of recurrence based on the 70-Gene or 21-Gene Risk classification. Although discordant results from multi-parametric assays are not uncommon, we postulate that here, discordance could suggest presence of heterogeneous cellular or molecular elements with invasive phenotype that could lead to aggressive transformations in the long run. Differential expression analysis between Luminal A cases with consistent subtyping and low risk prognostication and those with discordant subtyping or prognostication results revealed a panel of genes with significant changes in expression. Further analysis of RNA expression of these genes via Receiver Operating Characteristic (ROC) curve demonstrated that some genes showed high Area Under the Curve (AUC) scores in the classification between the two groups of Luminal A breast cancers, further supporting the existence of distinct molecular phenotypes. Targeted sequencing with Oncomine Comprehensive Assay V3 did not reveal particular mutational patterns between the two Luminal A groups. Nevertheless, radiomic analysis of mammographic images of the cancer, as well as single cell phenotyping of the tumor microenvironment with protein multiplexing will be incorporated to further characterise elements that are phenotypically different, and potentially identify mechanistic drivers contributing to late recurrence in Luminal A cancers. Citation Format: Alison M. Cheung, Dan Wang, Kela Liu, Yutaka Amemiya, Elzbieta Slodkowska, James G. Mainprize, Jane Bayani, Arun Seth, John Bartlett, Martin J. Yaffe. Integrative cross-platform characterisation of mammographic screen-detected breast cancer. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5622.

Analysis of coronal plane imaging features of automated breast volume scanner in different molecular subtypes of breast cancer

The Value of Automated Breast Volume Scanning, Combined with Virtual Touch Tissue Imaging Quantification in the Differential Diagnosis of Benign and Malignant Breast Lesion

Breast cancer subtypes based on ER/PR and Her2 expression: comparison of mr imaging features

Imaging Features of Automated Breast Volume Scanner: Correlation with Molecular Subtypes of Breast Cancer.

Abstract 5622: Integrative cross-platform characterisation of mammographic screen-detected breast cancer

Correlation of Automated Breast Volume Scanner Imaging and the Difference of Molecular Subtypes Between Core Needle Biopsy and Surgical Specimens

Automated breast volume scanner imaging features affecting difference of molecular subtypes between core needle biopsy and surgery in breast cancer

Diagnostic Value of Automated Breast Volume Scanner in Benign and Malignant Breast Lesions of Different Types of Ultrasound

Characterization of Breast Lesions: Comparison Between Three-dimensional Ultrasound and Automated Volume Breast Ultrasound

Comparison of Three Different Planes Obtained by Automated Breast Volume Scanner for the Observation of Margin ;characteristics of Breast Masses

Correlation analysis between mammographic features and different molecular subtypes of breast cancer

Analysis of eighty-one cases with breast lesions using automated breast volume scanner and comparison with handheld ultrasound

Correlation between retraction phenomenon on the coronal planes and biological behaviors of breast cancer

Radiomics Analysis of Breast Lesions in Combination with Coronal Plane of ABVS and Strain Elastography

The image performance of mucinous breast carcinoma on automated breast volume scanner and its pathologic features

Correlation of sonographic features with molecular subtypes in patients with breast cancer

Comparative analysis on three-dimensional assessment of breast invasive ductal carcinoma by conventional ultrasound and automated breast volume scanner

Molecular Markers, Pathology, and Ultrasound Features of Invasive Breast Cancer.

Molecular Imaging Using PET and SPECT for Identification of Breast Cancer Subtypes

Clinical research of automated breast volume scanner and MRI in diagnosis of breast cancer

Diagnostic Value of Three Dimensional Breast Ultrasound Coronal Imaging Features